News
The recall affects Dexcom G6, G7, ONE, and ONE+ continuous glucose monitor receivers but not the smartphone apps or insulin ...
Dexcom is recalling 19 models of its continuous glucose monitoring receivers due to a speaker malfunction that could prevent alerts for dangerous blood sugar levels. The affected devices are models ...
Dexcom is recalling certain Dexcom G6, G7, ONE, and ONE+ glucose monitoring receivers because of a problem with the speaker that may cause it to fail to make an alert sound when blood sugar is dangero ...
Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), is pleased to announce that coverage for Dexcom G6 ...
FDA recalls Dexcom glucose monitors (G6, G7, ONE models) due to alert issues posing severe health risks. Read more here.
In the past, patients may have waited two to six weeks for supplies, but now VA patients who are prescribed Dexcom G6 will be able to start CGM and refill supplies in just two to three days at ...
Dexcom, Inc. DXCM recently announced that its G6 continuous glucose monitoring ("CGM") System is now covered by the Non-Insured Health Benefits ("NIHB") program for diabetics aged between two and ...
Dexcom’s new G6 continuous glucose monitoring (CGM) ... who sometimes skimp on diabetes supplies despite clear FDA paramaters for use. Sayer said these stories frustrate him.
Proven to improve glycemic control and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 1 BURNABY, BC, May 26, 2021 /CNW Telbec/ - Dexcom ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results